Acute kidney injury in the ICU: Time has come for an early biomarker kit!

Acta Clinica Belgica

Volumn 62, Issue SUPPL. 2, 2007, Pages 318-321

  Honore, Patrick M ^a   Joannes Boyau, O ^b   Boer, W ^c   Janvier, G ^b   Gressens, B ^a  

^a Clinique Saint Pierre of Ottignies   (Belgium)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c Zuyderland Medical Centre   (Netherlands)

Author keywords

Acute kidney injury; AKI; Biomarker; Creatinine clearance; Haemofiltration; Review; Treatment

Indexed keywords

BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CREATININE; CYSTATIN; CYSTATIN C; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UNCLASSIFIED DRUG;

CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; DISEASE SEVERITY; HUMAN; INTENSIVE CARE UNIT; KIDNEY FUNCTION; KIDNEY INJURY; MORTALITY; ACUTE KIDNEY FAILURE; BLOOD; CLASSIFICATION; CRITICAL ILLNESS; GLOMERULUS FILTRATION RATE; HEMOFILTRATION; HOSPITALIZATION; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TIME; URINE;

BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CREATININE; CRITICAL ILLNESS; CYSTATINS; GLOMERULAR FILTRATION RATE; HEMOFILTRATION; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-18; KIDNEY FAILURE, ACUTE; MULTICENTER STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 41149160835     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2007.072     Document Type: Conference Paper

References (30)

1. Uchino S, Kellum JA, Bellomo R, et al. Beginning and Ending Supportive Therapy for the kidney (BEST Kidney) Investigators: Acute Renal Failure in critically ill patients: a multinational multicenter study. JAMA 2005; 294: 813-8.
2. Herget-Rosenthal S, Marggraf G, Husing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004; 66: 1115-22.
3. Khan IA, Wattanasuwan N. Role of biochemical markers in diagnosis of myocardial infarction. Int J Cardiol 2005; 104: 238-40.
4. Golstein SL. Kidney function assessment in the critically ill child: is it time to leave creatinine behind? Crit Care 2007; 11: R141.
5. Honore PM, Joannes-Boyau O, Boer W. The early biomarker of acute kidney injury: in search of the Holy Grail. Intensive Care Med 2007; 33: Jul 4: Epu Ahead of Print.
6. Herrero-Morin JD, Malaga S, Fernandez N, et al. Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill children. Crit Care 2007; 11: R 59.
7. Herrera-Gutierrez ME, Seller-Perez G, Banderas-Bravo E, et al. Replacement of 24-hour creatinine clearance by 2-hour creatinine clearance in intensive care units. A single-center study. Intensive Care Med 2007; 33: Jul 4: Epu Ahead of Print.
8. Hui-Stickle S, Brewer ED, Goldstein SL. Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 2005; 45: 96-101.
9. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004,8: 204-12.
10. Hoste EA, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006, 10: 73.
11. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005, 16: 3365-70.
12. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006; 15: 2756-8.
13. Bellomo R, Kellum JA, Ronco C. Defining acute renal failure: physiological principles. Intensive Care Med 2004; 30: 33-7.
14. Devarajan P. Emerging biomarkers of acute kidney injury. Contrib Nephrol 2007; 156: 203-12.
15. Han WK, Bonventre JV. Biologic markers for the early detection of acute kidney injury. Curr Opin Crit Care 2004; 10: 476-82.
16. Schrier RW. Need to intervene in established acute renal failure. J Am Soc Nephrol 2004; 15: 2756-8.
17. Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez-Bru C, Grubb A. Cystatin C as a marker of GFR-history, indications, and future research. Clin Biochem 2005; 38: 1-8.
18. Devarajan P, Mishra J, Supavekin S, Patterson LT, Potter SS. Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol Cenet Metab 2003; 80: 365-76.
19. Bagshaw S, Mortis G, Doig CJ, Godinez-Luna T, Fick GH, Laupland KB. One-year mortality in critically ill patients by severity of kidney dysfunction: a population-based assessment. Am J Kidney Dis 2006; 48: 402-9.
20. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 2004; 351: 159-69.
21. Mishra J, Mori K, Ma Q, Kelly C, Barasch J, Devarajan P. Neutrophil Gelatinase-Associated Lipocain (NGAL):A novel urinary biomarker for ischemic injury. J Am Soc Nephrol 2003; 4: 2534-43.
22. Delanaye P, Lambermont B, Chapelle JP, Gielen J, Gerard P, Rorive G. Plasmatic cystatin C for the estimation of glomerular filtration rate in intensive care units. Intensive Care Med 2004; 30: 980-3.
23. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1(KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int 2002; 62: 237-44.
24. Parikh CR, Mishra J, Thiessen-Philbrook H, et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006; 70: 199-203.
25. Mishra J, Dent C, Tarabishi R et al. Gelatinase-Associated Lipocain (NGAL) as a biomarker for acute renal injury following cardiac surgery. Lancet 2005; 365: 1231-8.
26. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40: 221-6.
27. Vandevoorde RG, Katlman TI, Ma Q, et al. Serum NGAL and cystatin C as predictive biomarkers for acute kidney injury. J Am Soc Nephrol 2006; 17: 404A.
28. Parikh CR, Jani A, Mishra J, et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006; 6: 1639-45.
29. Bianchi C, Donadio C, Tramonti G, Consani C, Lorusso P, Rossi G. Reappraisal of serum β2-microglobulin as marker of GFR. Ren Fail 2001, 23: 419-29.
30. Bagshaw SM, Langenberg C, Haase M, Wan L, May CN, Bellomo R. Urinary biomarkers in septic acute kidney injury. Intensive Care Med 2007 ; 33: 1285-96.